CD4 and lung carcinoma: Overall, our study has laid the foundation for addressing key questions in the field of lung cancer immunology and foreseeing the exploitation of activin-A-conditioned CD4+ T cells in future therapeutic modalities, in the context of adoptive T cell therapy.